SEC Form 4 · accession 0001209191-15-067820
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda Bain
Officer — Chief Financial Officer
Period of report
Aug 21, 2015
Accepted (ET)
Aug 25, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2015 | A | 32,930 | $0.00 | A | 41,930 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 50% of the shares subject thereto on each of the first and second anniversaries of August 21, 2015, subject to the Reporting Person's continued service with the Issuer. The RSUs are subject to acceleration pursuant to the Reporting Person's Change in Control and Severance Agreement, as amended.